188 related articles for article (PubMed ID: 25996410)
1. Epinecidin-1 antimicrobial activity: In vitro membrane lysis and In vivo efficacy against Helicobacter pylori infection in a mouse model.
Narayana JL; Huang HN; Wu CJ; Chen JY
Biomaterials; 2015 Aug; 61():41-51. PubMed ID: 25996410
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of the antimicrobial peptide TP4 against Helicobacter pylori infection: in vitro membrane perturbation via micellization and in vivo suppression of host immune responses in a mouse model.
Narayana JL; Huang HN; Wu CJ; Chen JY
Oncotarget; 2015 May; 6(15):12936-54. PubMed ID: 26002554
[TBL] [Abstract][Full Text] [Related]
3. The oligo-acyl lysyl antimicrobial peptide C₁₂K-2β₁₂ exhibits a dual mechanism of action and demonstrates strong in vivo efficacy against Helicobacter pylori.
Makobongo MO; Gancz H; Carpenter BM; McDaniel DP; Merrell DS
Antimicrob Agents Chemother; 2012 Jan; 56(1):378-90. PubMed ID: 22064541
[TBL] [Abstract][Full Text] [Related]
4. In vivo treatment of Helicobacter pylori infection with liposomal linolenic acid reduces colonization and ameliorates inflammation.
Thamphiwatana S; Gao W; Obonyo M; Zhang L
Proc Natl Acad Sci U S A; 2014 Dec; 111(49):17600-5. PubMed ID: 25422427
[TBL] [Abstract][Full Text] [Related]
5. CD4(+) Foxp3(+) regulatory T-cell number increases in the gastric tissue of C57BL/6 mice infected with Helicobacter pylori.
Liu S; Luo J; Liu Y; Tang S; Chen C; Cai H; Yu M; Zhang Y
APMIS; 2015 Jul; 123(7):571-9. PubMed ID: 26010562
[TBL] [Abstract][Full Text] [Related]
6. CD25+/Foxp3+ T cells regulate gastric inflammation and Helicobacter pylori colonization in vivo.
Rad R; Brenner L; Bauer S; Schwendy S; Layland L; da Costa CP; Reindl W; Dossumbekova A; Friedrich M; Saur D; Wagner H; Schmid RM; Prinz C
Gastroenterology; 2006 Aug; 131(2):525-37. PubMed ID: 16890606
[TBL] [Abstract][Full Text] [Related]
7. [Helicobacter pylori infection].
Kubota T; Fujioka T; Nasu M
Rinsho Byori; 1998 Jul; 46(7):623-8. PubMed ID: 9721527
[TBL] [Abstract][Full Text] [Related]
8. Anti-helicobacter pylori effect of total alkaloids of sophora alopecuroides in vivo.
Tian A; Xu T; Liu K; Zou Q; Yan X
Chin Med J (Engl); 2014; 127(13):2484-91. PubMed ID: 24985588
[TBL] [Abstract][Full Text] [Related]
9. Helicobacter pylori-induced Th17 responses modulate Th1 cell responses, benefit bacterial growth, and contribute to pathology in mice.
Shi Y; Liu XF; Zhuang Y; Zhang JY; Liu T; Yin Z; Wu C; Mao XH; Jia KR; Wang FJ; Guo H; Flavell RA; Zhao Z; Liu KY; Xiao B; Guo Y; Zhang WJ; Zhou WY; Guo G; Zou QM
J Immunol; 2010 May; 184(9):5121-9. PubMed ID: 20351183
[TBL] [Abstract][Full Text] [Related]
10. 'Rescue' therapies for the management of Helicobacter pylori infection.
Di Mario F; Cavallaro LG; Scarpignato C
Dig Dis; 2006; 24(1-2):113-30. PubMed ID: 16699270
[TBL] [Abstract][Full Text] [Related]
11. Selective killing of
Xiong M; Bao Y; Xu X; Wang H; Han Z; Wang Z; Liu Y; Huang S; Song Z; Chen J; Peek RM; Yin L; Chen LF; Cheng J
Proc Natl Acad Sci U S A; 2017 Nov; 114(48):12675-12680. PubMed ID: 29133389
[TBL] [Abstract][Full Text] [Related]
12. The design of vaccines against Helicobacter pylori and their development.
Del Giudice G; Covacci A; Telford JL; Montecucco C; Rappuoli R
Annu Rev Immunol; 2001; 19():523-63. PubMed ID: 11244046
[TBL] [Abstract][Full Text] [Related]
13. Antibacterial effects of the urushiol component in the sap of the lacquer tree (Rhus verniciflua Stokes) on Helicobacter pylori.
Suk KT; Baik SK; Kim HS; Park SM; Paeng KJ; Uh Y; Jang IH; Cho MY; Choi EH; Kim MJ; Ham YL
Helicobacter; 2011 Dec; 16(6):434-43. PubMed ID: 22059394
[TBL] [Abstract][Full Text] [Related]
14. Antigen-specific in vitro suppression of murine Helicobacter pylori-reactive immunopathological T cells by CD4CD25 regulatory T cells.
Raghavan S; Suri-Payer E; Holmgren J
Scand J Immunol; 2004; 60(1-2):82-8. PubMed ID: 15238076
[TBL] [Abstract][Full Text] [Related]
15. The importance of P-glycoprotein multidrug transporter activity measurement in patients with Helicobacter pylori infection.
Babić Z; Kucisec-Tepes N; Troskot R; Dorosulić Z; Svoboda-Beusan I
Coll Antropol; 2009 Dec; 33(4):1145-50. PubMed ID: 20102060
[TBL] [Abstract][Full Text] [Related]
16. FOXP3+ regulatory T cells in children with helicobacter pylori infection.
Cho KY; Cho MS; Seo JW
Pediatr Dev Pathol; 2012; 15(2):118-26. PubMed ID: 22260624
[TBL] [Abstract][Full Text] [Related]
17. Characterization of interleukin-1β in Helicobacter pylori-induced gastric inflammation and DNA methylation in interleukin-1 receptor type 1 knockout (IL-1R1(-/-)) mice.
Huang FY; Chan AO; Lo RC; Rashid A; Wong DK; Cho CH; Lai CL; Yuen MF
Eur J Cancer; 2013 Aug; 49(12):2760-70. PubMed ID: 23664095
[TBL] [Abstract][Full Text] [Related]
18. Mucosal immunization with a urease B DNA vaccine induces innate and cellular immune responses against Helicobacter pylori.
Hatzifoti C; Roussel Y; Harris AG; Wren BW; Morrow JW; Bajaj-Elliott M
Helicobacter; 2006 Apr; 11(2):113-22. PubMed ID: 16579841
[TBL] [Abstract][Full Text] [Related]
19. Pretreatment antimicrobial susceptibility-guided vs. clarithromycin-based triple therapy for Helicobacter pylori eradication in a region with high rates of multiple drug resistance.
Park CS; Lee SM; Park CH; Koh HR; Jun CH; Park SY; Lee WS; Joo YE; Kim HS; Choi SK; Rew JS
Am J Gastroenterol; 2014 Oct; 109(10):1595-602. PubMed ID: 25091062
[TBL] [Abstract][Full Text] [Related]
20. Role of Treg and TH17 cells of the gastric mucosa in children with Helicobacter pylori gastritis.
Gil JH; Seo JW; Cho MS; Ahn JH; Sung HY
J Pediatr Gastroenterol Nutr; 2014 Feb; 58(2):245-51. PubMed ID: 24121150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
